ARCHIVES

NCI Spent $381.2 Million On PR From 2006 to 2012, Vastly Outspending Other NIH, FDA Units

This article is from The Cancer Letter archive.

Vol. 39 No. 09 | March 1, 2013

Download PDF Visit The Full Archive

Related Articles

Cancer Act Renewals Marked By Disputes Over NCI Authorities

October 5, 1990

NIH Policy On Diversity In Sponsored Meetings

June 16, 1995

NCI Programs: U.S., U.K., Ireland Established Consortium For Cancer Research

October 15, 1999

NCI Promises Strong Monitoring Process Visco Calls For Independent Review; Rep. Dingell Plans Hearing April 13

April 1, 1994

Part II of Q&A With NCI Director Harold Varmus

July 29, 2011

Celebrex Studies Show Polyp Reduction, Point To Challenges In Biomarker Validation

April 28, 2006